---
title: 'CEO Attaché at molecule.xyz'
canonical: 'https://feeny.ai/job/ceo-attache-molecule-xyz-remote-tvc8fp16qp6k'
type: 'job'
last_seen: '2026-09-06'
---

# CEO Attaché at molecule.xyz

- **Company:** molecule.xyz
- **Location:** Remote
- **Employment:** full-time
- **Work type:** remote
- **Posted:** 2026-03-25
- **Last confirmed live:** 2026-09-06
- **Apply:** https://jobs.ashbyhq.com/molecule/aa419485-73ef-471a-a128-bfd683ca13b1

## Job description

Molecule and BIO.xyz are building the foundation of Decentralized Science (DeSci) — where biotech meets web3 to make scientific research community-owned, transparent, and faster to market.

Molecule provides the infrastructure to turn intellectual property (IP) into programmable, on-chain assets through our IP-NFT framework and evolving protocol stack. This enables researchers, patients, and communities to fund and govern biotech projects in new, open ways.

BIO.xyz http://Bio.xyz is the coordination and economic layer of DeSci, powering BioDAOs through funding, governance, and ecosystem alignment.

Together, we are creating a new model for scientific discovery — one where breakthroughs are owned and advanced by the communities that believe in them.

Full-time | Globally flexible, but US preferred - Travel required | Start: Immediately

We’re looking for a sharp, commercially-minded operator to work directly alongside Molecule’s CEO. This role sits at the centre of everything - driving BD pipeline, managing investor relationships, handling high-priority communications with enterprise pharma partners, and ensuring nothing falls through the cracks in a fast-moving organisation.

Molecule’s Commercial Team runs a high volume of concurrent partnerships across pharma, biotech, academic institutions, and investors. Deals get introduced, calls happen, and then things need someone relentless to keep them moving. You’ll work closely with the CEO and our Commercial Team to manage the pipeline, maintain investor relations across 70+ existing investors, and build the systems that make all of this scalable.

This is a role for someone who can context-switch between a pharma licensing conversation and an investor update without missing a beat - and who understands why what Molecule is building matters for the future of drug development.

## WHAT YOU’LL DO

- Own follow-through on BD pipeline - track active deal workstreams across enterprise, academic, and biotech partnerships, ensure nothing stalls, and surface the right opportunities to leadership at the right time
- Manage and build investor relations - maintain relationships with 70+ existing investors through regular updates, slide decks, and follow-ups, and drive new investor relationships forward alongside the CEO and the Commercial Team.
- Triage enterprise, pharma, and investor correspondence with sound commercial judgement
- Coordinate and prepare for high-stakes calls and meetings across time zones, ensuring the Team walks into every conversation fully briefed
- Draft and refine investor communications, partnership proposals, and internal updates on behalf of the Commercial Team
- Build and maintain a commercial system - create structure around how BD opportunities are categorised, tracked, and reported internally (think: our own lean CRM)
- Coordinate cross-functional deal activity - many of Molecule’s BD engagements span organisations and teams; you’ll be the connective tissue that keeps everyone aligned
- Analyse the science behind partnerships - evaluate incoming opportunities with enough scientific literacy to triage what’s worth pursuing and brief leadership accordingly
- Jump on calls with partners and investors as a credible representative of Molecule when needed

## WHO YOU ARE

- You have previously worked in a VC fund
- You’re commercially hungry. Whether you came from tech sales at a startup, BD at a health-tech company, or you taught yourself commercial skills alongside your academic work - you understand pipeline, follow-up, and what it takes to close
- You’re not typically corporate. We’re not looking for someone who climbed the ladder at a large pharma company. We want someone scrappy - think a biotech startup, or someone who hustled their way through a top programme and is now looking for real ownership
- You’re organised and relentless about follow-through. The biggest gap this role fills is making sure that the volume of relationships and deals Molecule generates don’t fall through the cracks
- You’re a strong communicator - equally comfortable drafting a board-level investor memo and hopping on a call with a lab partner or KOL
- You thrive in complexity and are energised by managing multiple priorities across deals, relationships, and internal coordination simultaneously
- You have global flexibility - ideally willing to spend the first several months in Berlin for onboarding and relationship-building with the core team

## NICE TO HAVE

- You have a have a scientific background - ideally a Master’s or PhD in life sciences, biotech, chemistry, or a related field - and you can engage credibly with researchers and pharma partners on the substance of what they do
- Familiarity with biotech IP licensing, research collaboration agreements, or venture deal structures
- Experience working across US and European markets and navigating international stakeholder relationships
- Interest in or exposure to decentralised science, Web3, or token-based funding models
- Experience building or managing a CRM or deal-tracking system from scratch

## WHY MOLECULE

- Exposure to enterprise pharma, institutional investors, and cutting-edge research partnerships globally
- A team that values substance over titles, speed over process, and people who’ve built their way up
- Competitive compensation including token-based upside

We are an equal opportunity employer. We are committed to equality and weaving a community that values diverse perspectives and experiences and are actively seeking a diverse pool of applicants. All employment decisions are made without regard to race, colour, national origin, ancestry, sex, gender, gender identity or expression, sexual orientation, age, genetic information, religion, disability, medical condition, pregnancy, marital status, family status, veteran status, or any other characteristic protected by law.

## About molecule.xyz

## Company Overview
- **One-liner**: Molecule builds onchain infrastructure for tokenizing, funding, and accelerating scientific research, enabling autonomous AI-driven science and liquid intellectual property markets.
- **Entity Type**: Private (Web3 / DeSci startup)
- **Headquarters**: Not publicly available (remote-first, team distributed globally)
- **Founded**: 2020
- **Founders**: Paul Kohlhaas (Founder and Chairman), Aaron Weaver (Chief Commercial Officer, Co-Founder)

## Core Business
- **Primary industry**: Decentralized Science (DeSci), Biotechnology, Web3 Infrastructure
- **Target customers**: Researchers, biotech labs, scientific institutions, Web3 investors, AI agent developers, and pharmaceutical companies
- **Mission**: "Propel science from lab to life, fueled by a community committed to human progress" — democratizing drug development and scientific research funding through onchain infrastructure.

## Products & Services
- **Onchain Lab**: A modular smart contract wallet (ERC-7579) that acts as a sovereign, programmable container for research projects. It holds assets, executes transactions, stores data references, and interacts with protocols under a persistent onchain identity. Supports IP tokenization, fractionalized ownership, and AI agent execution.
- **IP-NFTs & IP Tokens**: Tokenization of intellectual property as NFTs, with fractionalized ownership via tokens, enabling liquid markets for scientific IP, crowdsales, and automated royalty/licensing via smart contracts.
- **Data Infrastructure & DeSci API**: Decentralized data storage (IPFS, Arweave) with provenance tracking, encryption, and granular access control (token-gated, credential-gated, payment-gated). The DeSci API provides programmatic read/write access to Lab data rooms.
- **BioAgents (AI Agent Layer)**: An open-source AI scientist framework (by bio.xyz) integrated as an executor module on Labs. Agents autonomously analyze data, generate hypotheses, and publish findings with full onchain provenance, operating in Fully Autonomous or Human-Directed modes.

## Market Standing
- **Valuation**: Not publicly disclosed
- **Total Funding**: Not publicly disclosed (backed by prominent Web3 and DeSci investors)
- **Notable Investors/Partners**: bio.xyz (ecosystem partner), community of scientists, researchers, and Web3 investors; part of the broader DeSci movement alongside projects like VitaDAO
- **Growth Signals**: Molecule has been operating for over 5 years, evolving from a coordination layer to a full programmable science economy. The launch of "Labs" architecture (Feb 2026) represents a major technical evolution, integrating AI agents (BioAgents) and modular smart contract standards (ERC-4337, ERC-6551, ERC-7579). The platform has successfully tokenized multiple real-world biopharma IP assets, creating a growing ecosystem of onchain science.

## Competitive Advantages
- **First-mover in DeSci infrastructure**: Molecule is one of the earliest and most established platforms for tokenizing biopharma IP onchain, with a track record of real-world scientific assets.
- **Integrated AI agent layer**: The BioAgents integration creates a closed loop where AI agents autonomously operate within Labs, generating hypotheses and analyzing data with full onchain provenance — a unique moat in scientific research infrastructure.
- **Modular, standards-based architecture**: Built on ERC-4337, ERC-6551, and ERC-7579, Labs are sovereign, transferable, and extensible — allowing new capabilities (licensing, governance, oracles) to be installed over time.
- **Liquid IP markets**: IP-NFTs and IP Tokens make traditionally illiquid scientific intellectual property tradable, fractionalizable, and investable — creating a new asset class.

## Strategic Focus
- **Scaling the Labs ecosystem**: Transitioning from a coordination layer to a full programmable science economy where researchers can go from idea to market entirely onchain.
- **AI agent integration**: Deepening the integration of autonomous AI agents (BioAgents) to enable continuous, self-driving scientific research within Labs.
- **Building developer and researcher adoption**: Growing the ecosystem of modules, integrations, and users around the Onchain Lab standard.
- **Tokenizing real-world biopharma IP**: Continuing to bring high-value scientific assets onchain, creating liquid markets for intellectual property.

## Why Work Here
- **Mission-driven**: Directly contribute to accelerating cures and democratizing science funding — work that has tangible impact on human health and progress.
- **Remote-first, global team**: Distributed team with multiple in-person off-sites per year; strong emphasis on autonomy and ownership.
- **Competitive compensation**: Salary + token + equity packages benchmarked against leading biotech and Web3 companies.
- **Generous benefits**: PTO, learning & development budget, paid travel to conferences and scientific events, team off-sites.
- **High-agency culture**: Values include purpose, innovation, autonomy, care, and high standards. The team moves fast, communicates clearly, and values scientific curiosity and operational rigor.
- **Hiring process**: Application → screening → practical hiring challenge (domain-specific) → interviews with teammates and leadership → decision within days. Designed to mimic real work, not trivia.
- **Open roles**: Senior Product Manager, Senior Web3 Engineer, Senior Finance Manager, Full Stack Engineer, dApp Protocol Engineer, and more — all listed on [jobs.ashbyhq.com/molecule](https://jobs.ashbyhq.com/molecule).

## Sources
1. [molecule.xyz](https://molecule.xyz/about-us)
2. [molecule.xyz](https://molecule.xyz/careers)
3. [docs.molecule.xyz](https://docs.molecule.xyz/)
4. [molecule.xyz](https://molecule.xyz/blog/inside-molecules-biggest-technical-overhaul)
5. [molecule.xyz](https://www.molecule.xyz/how-it-works)
6. [jobs.ashbyhq.com](https://jobs.ashbyhq.com/molecule)

## Other roles at molecule.xyz

- [Pharmacist](https://feeny.ai/job/pharmacist-molecule-xyz-germany-s3pkq7vsmz3q) — Germany
- [Paralegal](https://feeny.ai/job/paralegal-molecule-xyz-remote-ant91m71jy2q)
- [AI Scientist - Entrepreneur in Residence](https://feeny.ai/job/ai-scientist-entrepreneur-in-residence-molecule-xyz-remote-akb2jmnwjk5c)